ALPHAMAB-B(09966) announces profit expectation, expected to achieve annual profit for the first time in 2024 with profits of no less than 150 million yuan.
Kangning Jerui Pharmaceuticals - B (09966) announced that the group is expected to end on December 31, 2024...
ALPHAMAB-B (09966) announced that the group is expected to achieve a profit of no less than RMB 150 million for the year ending December 31, 2024, while it incurred a loss of approximately RMB 210.6 million for the year ending December 31, 2023. This marks the first time the company has achieved an annual profit.
The announcement stated that the company has turned a loss into a profit during the reporting period, mainly due to three authorized cooperation and sales revenue.
Related Articles
GEELY AUTO (00175) issued 22,000 shares on September 17 due to the exercise of stock options.
LAEKNA-B (02105) completed the issue of 36 million shares of allocated shares.
CHANJET (01588) obtained that the controlling shareholder reduced its holding of 42.1078 million shares, lowering its stake to approximately 53.53%.
GEELY AUTO (00175) issued 22,000 shares on September 17 due to the exercise of stock options.
LAEKNA-B (02105) completed the issue of 36 million shares of allocated shares.
CHANJET (01588) obtained that the controlling shareholder reduced its holding of 42.1078 million shares, lowering its stake to approximately 53.53%.
